Search research articles
Contact Us
Filters
Showing results (51-60 of 322) with videos related to
Page
of 33
Sort By:
Current Opinion in Pulmonary Medicine
|
January 22, 2011
Healthcare-associated pneumonia: the state of evidence to date
Marya D Zilberberg, Andrew F Shorr
Critical Care Medicine
|
May 19, 2009
Red blood cell transfusion in the critically ill: when is it time to say enough?
Howard L Corwin, Andrew F Shorr
Chest
|
November 12, 2016
Going Viral: Importance of Viral Pathogens in Nonventilated Hospital-Acquired Pneumonia
Andrew F Shorr, Marya D Zilberberg
Expert Review of Anti-Infective Therapy
|
January 26, 2017
Response to: 'letter to the editor: "Challenges and opportunities in the treatment of ventilator-associated pneumonia"'
Matthew P Schreiber, Andrew F Shorr
Critical Care Medicine
|
June 9, 2005
Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign
William L Jackson, Andrew F Shorr
Chest
|
February 7, 2008
Not everything that can be counted counts
Lee E Morrow, Andrew F Shorr
Critical Care (London, England)
|
December 21, 2022
Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP
Andrew F Shorr, Marya D Zilberberg
BMJ Open
|
December 21, 2012
Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation
Marya D Zilberberg, Andrew F Shorr
BMC Health Services Research
|
September 4, 2007
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation
Marya D Zilberberg, Andrew F Shorr
Thrombosis and Haemostasis
|
January 10, 2009
Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis
Andrew F Shorr, Mark D Williams
Page
of 33
Search research articles
Search
Showing results (51-60 of 322) with videos related to
Sort By:
Page
of 33
Current Opinion in Pulmonary Medicine
|
January 22, 2011
Healthcare-associated pneumonia: the state of evidence to date
Marya D Zilberberg, Andrew F Shorr
Critical Care Medicine
|
May 19, 2009
Red blood cell transfusion in the critically ill: when is it time to say enough?
Howard L Corwin, Andrew F Shorr
Chest
|
November 12, 2016
Going Viral: Importance of Viral Pathogens in Nonventilated Hospital-Acquired Pneumonia
Andrew F Shorr, Marya D Zilberberg
Expert Review of Anti-Infective Therapy
|
January 26, 2017
Response to: 'letter to the editor: "Challenges and opportunities in the treatment of ventilator-associated pneumonia"'
Matthew P Schreiber, Andrew F Shorr
Critical Care Medicine
|
June 9, 2005
Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign
William L Jackson, Andrew F Shorr
Chest
|
February 7, 2008
Not everything that can be counted counts
Lee E Morrow, Andrew F Shorr
Critical Care (London, England)
|
December 21, 2022
Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP
Andrew F Shorr, Marya D Zilberberg
BMJ Open
|
December 21, 2012
Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation
Marya D Zilberberg, Andrew F Shorr
BMC Health Services Research
|
September 4, 2007
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation
Marya D Zilberberg, Andrew F Shorr
Thrombosis and Haemostasis
|
January 10, 2009
Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis
Andrew F Shorr, Mark D Williams
Page
of 33